Tumor immunology - When a cancer cell meets the immune cells

Bor Ching Sheu, Su Ming Hsu, Hong Nerng Ho, Rong Hwa Lin, Su Cheng Huang

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Tumor immunology consists of two essential concepts: immune surveillance, which specifies the host immune reactions against tumor cells, and tumor immune escape, which refers to the tumor-cell evasion process against the host immune system. Effective antitumor immunity by the host immune surveillance is supposed to be dependent on the identification of tumor antigens. In the process of malignant transformation, genetic mutations with aberrant expression of cancer-related genes and protein products are potentially immunogenic, which may serve as rejection antigens. Several scenarios are proposed to be responsible for tumor immune-escape mechanisms. The elucidation of the immune deficit against cancer progression has been a difficult task and no solitary mechanism explains the complicated cancer-host immune interactions. Cancer cells may overcome immune surveillance through a common but effective pathway, either by changing the polarity of effector cells, thus down-regulating the proliferation of tumor-specific cytotoxic T cells, or altering the effector compositions of immune cells within the tumor milieu, or both. Understanding the interaction between cancer cells and host immune cells within the tumor milieu is of importance for further clinical applications of immunotherapy in cancer treatment.

Original languageEnglish
Pages (from-to)730-735
Number of pages6
JournalJournal of the Formosan Medical Association
Volume98
Issue number11
Publication statusPublished - Nov 1 1999
Externally publishedYes

Fingerprint

Tumor-Infiltrating Lymphocytes
Immune Tolerance
Histocompatibility Antigens Class I
Histocompatibility Antigens Class II
Neoplasm Antigens
Allergy and Immunology
Natural Killer Cells
Cytokines
Neoplasms
Tumor Escape
Genetic Transformation
Cell Polarity
Neoplasm Genes
Immunotherapy
Immune System
Immunity

Keywords

  • Immune escape
  • Immune surveillance
  • Tumor immunology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sheu, B. C., Hsu, S. M., Ho, H. N., Lin, R. H., & Huang, S. C. (1999). Tumor immunology - When a cancer cell meets the immune cells. Journal of the Formosan Medical Association, 98(11), 730-735.

Tumor immunology - When a cancer cell meets the immune cells. / Sheu, Bor Ching; Hsu, Su Ming; Ho, Hong Nerng; Lin, Rong Hwa; Huang, Su Cheng.

In: Journal of the Formosan Medical Association, Vol. 98, No. 11, 01.11.1999, p. 730-735.

Research output: Contribution to journalReview article

Sheu, BC, Hsu, SM, Ho, HN, Lin, RH & Huang, SC 1999, 'Tumor immunology - When a cancer cell meets the immune cells', Journal of the Formosan Medical Association, vol. 98, no. 11, pp. 730-735.
Sheu, Bor Ching ; Hsu, Su Ming ; Ho, Hong Nerng ; Lin, Rong Hwa ; Huang, Su Cheng. / Tumor immunology - When a cancer cell meets the immune cells. In: Journal of the Formosan Medical Association. 1999 ; Vol. 98, No. 11. pp. 730-735.
@article{04233c34f1da4cb7885830460cfb8960,
title = "Tumor immunology - When a cancer cell meets the immune cells",
abstract = "Tumor immunology consists of two essential concepts: immune surveillance, which specifies the host immune reactions against tumor cells, and tumor immune escape, which refers to the tumor-cell evasion process against the host immune system. Effective antitumor immunity by the host immune surveillance is supposed to be dependent on the identification of tumor antigens. In the process of malignant transformation, genetic mutations with aberrant expression of cancer-related genes and protein products are potentially immunogenic, which may serve as rejection antigens. Several scenarios are proposed to be responsible for tumor immune-escape mechanisms. The elucidation of the immune deficit against cancer progression has been a difficult task and no solitary mechanism explains the complicated cancer-host immune interactions. Cancer cells may overcome immune surveillance through a common but effective pathway, either by changing the polarity of effector cells, thus down-regulating the proliferation of tumor-specific cytotoxic T cells, or altering the effector compositions of immune cells within the tumor milieu, or both. Understanding the interaction between cancer cells and host immune cells within the tumor milieu is of importance for further clinical applications of immunotherapy in cancer treatment.",
keywords = "Immune escape, Immune surveillance, Tumor immunology",
author = "Sheu, {Bor Ching} and Hsu, {Su Ming} and Ho, {Hong Nerng} and Lin, {Rong Hwa} and Huang, {Su Cheng}",
year = "1999",
month = "11",
day = "1",
language = "English",
volume = "98",
pages = "730--735",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - Tumor immunology - When a cancer cell meets the immune cells

AU - Sheu, Bor Ching

AU - Hsu, Su Ming

AU - Ho, Hong Nerng

AU - Lin, Rong Hwa

AU - Huang, Su Cheng

PY - 1999/11/1

Y1 - 1999/11/1

N2 - Tumor immunology consists of two essential concepts: immune surveillance, which specifies the host immune reactions against tumor cells, and tumor immune escape, which refers to the tumor-cell evasion process against the host immune system. Effective antitumor immunity by the host immune surveillance is supposed to be dependent on the identification of tumor antigens. In the process of malignant transformation, genetic mutations with aberrant expression of cancer-related genes and protein products are potentially immunogenic, which may serve as rejection antigens. Several scenarios are proposed to be responsible for tumor immune-escape mechanisms. The elucidation of the immune deficit against cancer progression has been a difficult task and no solitary mechanism explains the complicated cancer-host immune interactions. Cancer cells may overcome immune surveillance through a common but effective pathway, either by changing the polarity of effector cells, thus down-regulating the proliferation of tumor-specific cytotoxic T cells, or altering the effector compositions of immune cells within the tumor milieu, or both. Understanding the interaction between cancer cells and host immune cells within the tumor milieu is of importance for further clinical applications of immunotherapy in cancer treatment.

AB - Tumor immunology consists of two essential concepts: immune surveillance, which specifies the host immune reactions against tumor cells, and tumor immune escape, which refers to the tumor-cell evasion process against the host immune system. Effective antitumor immunity by the host immune surveillance is supposed to be dependent on the identification of tumor antigens. In the process of malignant transformation, genetic mutations with aberrant expression of cancer-related genes and protein products are potentially immunogenic, which may serve as rejection antigens. Several scenarios are proposed to be responsible for tumor immune-escape mechanisms. The elucidation of the immune deficit against cancer progression has been a difficult task and no solitary mechanism explains the complicated cancer-host immune interactions. Cancer cells may overcome immune surveillance through a common but effective pathway, either by changing the polarity of effector cells, thus down-regulating the proliferation of tumor-specific cytotoxic T cells, or altering the effector compositions of immune cells within the tumor milieu, or both. Understanding the interaction between cancer cells and host immune cells within the tumor milieu is of importance for further clinical applications of immunotherapy in cancer treatment.

KW - Immune escape

KW - Immune surveillance

KW - Tumor immunology

UR - http://www.scopus.com/inward/record.url?scp=0033383030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033383030&partnerID=8YFLogxK

M3 - Review article

C2 - 10705688

AN - SCOPUS:0033383030

VL - 98

SP - 730

EP - 735

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 11

ER -